Literature DB >> 9212421

The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo.

M F Bernet-Camard1, V Liévin, D Brassart, J R Neeser, A L Servin, S Hudault.   

Abstract

The adhering human Lactobacillus acidophilus strain LA1 inhibits the cell association and cell invasion of enteropathogens in cultured human intestinal Caco-2 cells (M. F. Bernet, D. Brassard, J. R. Neeser, and A. L. Servin, Gut 35:483-489, 1994). Here, we demonstrate that strain LA1 developed its antibacterial activity in conventional or germ-free mouse models orally infected by Salmonella typhimurium. We present evidence that the spent culture supernatant of strain LA1 (LA1-SCS) contained antibacterial components active against S. typhimurium infecting the cultured human intestinal Caco-2 cells. The LA1-SCS antibacterial activity was observed in vitro against a wide range of gram-negative and gram-positive pathogens, such as Staphylococcus aureus, Listeria monocytogenes, S. typhimurium, Shigella flexneri, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Enterobacter cloacae. By contrast, no activity was observed against species of the normal gut flora, such as lactobacilli and bifidobacteria. The LA1-SCS antibacterial activity was insensitive to proteases and independent of lactic acid production.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9212421      PMCID: PMC168570          DOI: 10.1128/aem.63.7.2747-2753.1997

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  43 in total

1.  Microcin 25, a novel antimicrobial peptide produced by Escherichia coli.

Authors:  R A Salomón; R N Farías
Journal:  J Bacteriol       Date:  1992-11       Impact factor: 3.490

Review 2.  Potential of using lactic acid bacteria for therapy and immunomodulation in man.

Authors:  P Marteau; J C Rambaud
Journal:  FEMS Microbiol Rev       Date:  1993-09       Impact factor: 16.408

3.  Competitive exclusion of diarrheagenic Escherichia coli (ETEC) from human enterocyte-like Caco-2 cells by heat-killed Lactobacillus.

Authors:  G Chauvière; M H Coconnier; S Kerneis; A Darfeuille-Michaud; B Joly; A L Servin
Journal:  FEMS Microbiol Lett       Date:  1992-03-15       Impact factor: 2.742

4.  Protein-mediated adhesion of Lactobacillus acidophilus BG2FO4 on human enterocyte and mucus-secreting cell lines in culture.

Authors:  M H Coconnier; T R Klaenhammer; S Kernéis; M F Bernet; A L Servin
Journal:  Appl Environ Microbiol       Date:  1992-06       Impact factor: 4.792

5.  Adhesion of human Lactobacillus acidophilus strain LB to human enterocyte-like Caco-2 cells.

Authors:  G Chauvière; M H Coconnier; S Kernéis; J Fourniat; A L Servin
Journal:  J Gen Microbiol       Date:  1992-08

Review 6.  Genetics of bacteriocins produced by lactic acid bacteria.

Authors:  T R Klaenhammer
Journal:  FEMS Microbiol Rev       Date:  1993-09       Impact factor: 16.408

7.  Inhibition of adhesion of enteroinvasive pathogens to human intestinal Caco-2 cells by Lactobacillus acidophilus strain LB decreases bacterial invasion.

Authors:  M H Coconnier; M F Bernet; S Kernéis; G Chauvière; J Fourniat; A L Servin
Journal:  FEMS Microbiol Lett       Date:  1993-07-01       Impact factor: 2.742

8.  Inhibition of adhesion of Escherichia coli K88 to piglet ileal mucus by Lactobacillus spp.

Authors:  L Blomberg; A Henriksson; P L Conway
Journal:  Appl Environ Microbiol       Date:  1993-01       Impact factor: 4.792

9.  Summary of conclusions from a consensus panel of experts on health attributes of lactic cultures: significance to fluid milk products containing cultures.

Authors:  M E Sanders
Journal:  J Dairy Sci       Date:  1993-07       Impact factor: 4.034

10.  Antimicrobial compounds from Lactobacillus casei and Lactobacillus helveticus.

Authors:  M Vescovo; G L Scolari; L Caravaggi; V Bottazzi
Journal:  New Microbiol       Date:  1993-04       Impact factor: 2.479

View more
  70 in total

1.  pH-, Lactic acid-, and non-lactic acid-dependent activities of probiotic Lactobacilli against Salmonella enterica Serovar Typhimurium.

Authors:  Domitille Fayol-Messaoudi; Cédric N Berger; Marie-Hélène Coconnier-Polter; Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Appl Environ Microbiol       Date:  2005-10       Impact factor: 4.792

2.  Probiotics reduce enterohemorrhagic Escherichia coli O157:H7- and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements.

Authors:  Philip M Sherman; Kathene C Johnson-Henry; Helen P Yeung; Peter S C Ngo; Jacques Goulet; Thomas A Tompkins
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

Review 3.  The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

Review 4.  Proposed model: mechanisms of immunomodulation induced by probiotic bacteria.

Authors:  C Maldonado Galdeano; A de Moreno de LeBlanc; G Vinderola; M E Bibas Bonet; G Perdigón
Journal:  Clin Vaccine Immunol       Date:  2007-03-14

Review 5.  The role of probiotics in management of irritable bowel syndrome.

Authors:  Anna M Borowiec; Richard N Fedorak
Journal:  Curr Gastroenterol Rep       Date:  2007-10

6.  In vitro anti-Helicobacter pylori activity of the probiotic strain Bacillus subtilis 3 is due to secretion of antibiotics.

Authors:  I V Pinchuk; P Bressollier; B Verneuil; B Fenet; I B Sorokulova; F Mégraud; M C Urdaci
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

7.  Escherichia coli 83972 inhibits catheter adherence by a broad spectrum of uropathogens.

Authors:  Barbara W Trautner; Richard A Hull; Rabih O Darouiche
Journal:  Urology       Date:  2003-05       Impact factor: 2.649

Review 8.  Potential uses of probiotics in clinical practice.

Authors:  Gregor Reid; Jana Jass; M Tom Sebulsky; John K McCormick
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

9.  Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB.

Authors:  M H Coconnier; V Lievin; E Hemery; A L Servin
Journal:  Appl Environ Microbiol       Date:  1998-11       Impact factor: 4.792

10.  Effect of Weissella confusa strain PL9001 on the adherence and growth of Helicobacter pylori.

Authors:  Hyeran Nam; Misun Ha; On Bae; Yeonhee Lee
Journal:  Appl Environ Microbiol       Date:  2002-09       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.